Orsiro Mission Adverse Events: FDA MAUDE Data

BIOTRONIK SE & Co. KG · Coronary Drug-Eluting Stent · First cleared Sep 2024

Total Reports

632

Reports (30d)

25

Active Signals

2

Open Recalls

0

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Inability to Cross Severely Calcified Lesion

stent selected, mission drug, orsiro mission, orsiro, affected device

68

reports

2

Stent Dislodgement During Introduction

dislodgement occurred, patient complications, advanced treatment, synergy drug, stent advanced

1

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Active safety signals

Increasing trendcriticalDisproportionate reportinghigh

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 2 active signals detected right now.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.